Navigation Links
ARISE INFUSION THERAPY SERVICES Now Infusing Ocrevustm (Ocrelizumab) For Relapsing and Primary Progressive Forms of Multiple Sclerosis
Date:7/26/2017

Written By: Ashley D. Beall, MD, FACR

Arise Infusion is pleased to now offer a major advancement in drug therapy for patients living with relapsing and primary multiple sclerosis that can significantly improve their lives. Ocrevus (pronounced Ah-creh-vus) is a novel B cell targeted therapy that has been proven to significantly reduce signs of disease activity and mitigate the progressive disability that individuals afflicted with this disease often experience. “This new biologic treatment provides hope for individuals that have not had any available FDA-approved therapies. We are committed to helping those who can benefit with access to this medication”, said Ashley Beall, MD, FACR, Medical Director of Arise Infusion.

OCREVUS became available to patients in the U.S. in March of this year after receiving FDA approval for the treatment of multiple sclerosis. OCREVUS is administered by intravenous infusion by a nurse and is only available at a licensed infusion center. The first dose is given as two 300 mg infusions two weeks apart. Subsequent doses are given as single 600 mg infusions every six months. Arise Infusion Therapy Services is one of the first infusion centers in the metropolitan Washington DC area to offer this treatment. Arise Infusion is committed to helping patients access this exciting new treatment by handling the pre-authorization process and helping to secure co-payment assistance for those in need.

About multiple sclerosis
Multiple sclerosis (MS) is a chronic disease for which there is currently no cure. MS affects an estimated 400,000 people in the U.S. The disease occurs when the body’s immune system attacks the insulation (myelin sheath) surrounding its own nerve cells in the brain, spinal cord and optic nerves, causing inflammation that disrupts nerve impulses. This damage can lead to a wide range of symptoms, including muscle weakness, fatigue and visual changes, and may eventually lead to disability. Most people with MS experience their first symptom between 20 and 40 years of age, making the disease the leading cause of non-traumatic disability in younger adults.  

ARISE INFUSION THERAPY SERVICES has five conveniently located centers in the Washington D.C. metropolitan area that provide safe and cost-effective infusion therapy.  Arise Infusion centers are modern and attractive with many amenities to ensure patients’ comfort.  Arise treats patients with auto-immune and inflammatory conditions who aren’t so sick that they need to be treated in a hospital and aren’t so frail that they require home care. Emphasizing a “safety first” philosophy, Arise Infusion centers are staffed with highly trained registered nurses working under physician supervision. The offices are bright, cheerful places where people come to manage their conditions so they can lead full and productive lives.

The Arise Infusion team helps to manage all issues related to insurance pre-authorization, payment arrangements, and scheduling to ensure a smooth and pleasant infusion experience.  

For more information regarding Arise Infusion visit our website at http://www.ariseinfusion.com or call 240-514-5000.

Read the full story at http://www.prweb.com/releases/2017/07/prweb14547186.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Highly drug resistant, virulent strain of Pseudomonas aeruginosa arises in Ohio
2. RE/MAX Agent Charise Goodnight Helps Children in Need Have a Good Day
3. Promising Results Arise from Phase 2 Vaccine Study for Mesothelioma
4. Magnesium Infusion: Review Examines Ian Clark's New Pure Magnesium Product
5. InfusionPoints, LLC Achieves ISO 9001:2008 Certification
6. Medtronic Infusion Pump Recall Lawyers: Resource4thePeople Announces Free Consultations Will Be Available over the Holidays
7. Transparency Market Research Adds Report on Global Infusion System Market to its Repository
8. Asia-Pacific Market for Infusion Therapy Devices Led by Terumo, JMS and Nipro Medical is expected to reach over $900 million by 2020
9. APAC Infusion Therapy Device Market Analysed and Forecast in New iData Research Study Available at MarketPublishers.com
10. Infusion Pumps Market: An Overview of Growth Prospects and Market Restraints: Transparency Market Research
11. Global Medical Robotic Systems Market Will Be Driven By Infusion Of Technology In Medical Devices Industry From 2014 To 2020: Grand View Research, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2019)... Okla. (PRWEB) , ... September 14, 2019 , ... ... cannabis industry, has time and again tried to bring the most relevant and important ... ray of hope on an increasingly large number of people across the world suffering ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful source of ... disease as he hopes to prevent anyone from having it and to help those ... Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to experience another ...
(Date:9/11/2019)... ... 2019 , ... A September 2 article on CBS News details ... less likely to suffer heart attacks, strokes, kidney failure, and heart disease versus a ... loss surgery specialists Dr. Feiz and Associates says the study adds further evidence to ...
(Date:9/11/2019)... GOLDEN VALLEY, Minn. (PRWEB) , ... September 11, ... ... Symposium (MACKIS) conference will be held September 11-14 in Minneapolis at the Mall ... chairman Dr. Robert LaPrade, will be faculty members for the high-profile, knee-focused conference, ...
(Date:9/11/2019)... ... 2019 , ... RMA of Connecticut , a leading fertility practice whose ... free informational event that will demystify fertility age-related issues and will include complimentary ... registrants. The event, “What’s Your Real Fertility Age,” will take place on Wednesday, October ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... September 13, 2019 , ... St. Joseph’s ... to celebrate the structural topping out of the St. Joseph’s Hospital patient tower ... include a new six-story patient tower that will house a two-story lobby, waiting ...
(Date:9/12/2019)... ... September 12, 2019 , ... ... EHR , revenue cycle management services, integrated practice management, and patient engagement ... Grand Sponsor at National User Conference (NUCON) 2019 . The annual ...
(Date:9/11/2019)... ... September 11, 2019 , ... Radiology… ... companies developing technologies to evaluate medical images. In fact, image analysis software represents ... the FDA is taking to AI-based image analysis, one will be left behind. ...
Breaking Medicine Technology: